Bio-Rad Laboratories, Inc. (BIO)
381.57
+12.57
(+3.41%)
USD |
NYSE |
Nov 06, 16:00
381.67
+0.10
(+0.03%)
Pre-Market: 20:00
Bio-Rad Laboratories Free Cash Flow : 353.10M for Sept. 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 353.10M |
| March 31, 2026 | 357.20M |
| December 31, 2025 | 374.60M |
| September 30, 2025 | 336.76M |
| June 30, 2025 | 370.94M |
| March 31, 2025 | 355.50M |
| December 31, 2024 | 289.00M |
| September 30, 2024 | 246.55M |
| June 30, 2024 | -214.82M |
| March 31, 2024 | 171.02M |
| December 31, 2023 | 218.26M |
| September 30, 2023 | 1.465B |
| June 30, 2023 | 424.81M |
| March 31, 2023 | 352.95M |
| December 31, 2022 | 1.322B |
| September 30, 2022 | -933.41M |
| June 30, 2022 | 640.05M |
| March 31, 2022 | 401.93M |
| December 31, 2021 | -549.18M |
| September 30, 2021 | 1.457B |
| June 30, 2021 | 1.024B |
| March 31, 2021 | 701.15M |
| December 31, 2020 | 476.41M |
| September 30, 2020 | -421.09M |
| June 30, 2020 | -115.41M |
| Date | Value |
|---|---|
| March 31, 2020 | 209.37M |
| December 31, 2019 | 359.36M |
| September 30, 2019 | 272.30M |
| June 30, 2019 | 243.86M |
| March 31, 2019 | 161.82M |
| December 31, 2018 | 155.67M |
| September 30, 2018 | 147.82M |
| June 30, 2018 | 115.89M |
| March 31, 2018 | 97.70M |
| December 31, 2017 | -10.99M |
| September 30, 2017 | -4.405M |
| June 30, 2017 | -0.548M |
| March 31, 2017 | 12.07M |
| December 31, 2016 | 74.86M |
| September 30, 2016 | 32.95M |
| June 30, 2016 | 78.28M |
| March 31, 2016 | 39.04M |
| December 31, 2015 | 72.84M |
| September 30, 2015 | 65.48M |
| June 30, 2015 | 70.67M |
| March 31, 2015 | 107.26M |
| December 31, 2014 | 136.83M |
| September 30, 2014 | 179.82M |
| June 30, 2014 | 155.24M |
| March 31, 2014 | 106.48M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Thermo Fisher Scientific, Inc. | 7.596B |
| Danaher Corp. | 5.727B |
| Agilent Technologies, Inc. | 1.267B |
| Illumina, Inc. | 637.00M |
| Bruker Corp. | 244.70M |